{"id":"NCT00068601","sponsor":"SWOG Cancer Research Network","briefTitle":"S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer","officialTitle":"Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10","primaryCompletion":"2014-01","completion":"2016-09","firstPosted":"2003-09-11","resultsPosted":"2017-04-04","lastUpdate":"2019-12-30"},"enrollment":257,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Breast Cancer","Infertility","Menopausal Symptoms"],"interventions":[{"type":"DRUG","name":"cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"goserelin acetate","otherNames":[]}],"arms":[{"label":"Standard Chemotherapy","type":"ACTIVE_COMPARATOR"},{"label":"Chemotherapy Plus Goserelin","type":"EXPERIMENTAL"}],"summary":"RATIONALE: Goserelin blocks hormone production in the ovaries. It is not yet known whether ovarian suppression using goserelin will prevent ovarian failure (early menopause) in women receiving chemotherapy for breast cancer.\n\nPURPOSE: This randomized phase III trial is studying how well giving goserelin together with chemotherapy works compared with chemotherapy alone in preventing early menopause in women with stage I, stage II, or stage IIIA breast cancer.","primaryOutcome":{"measure":"Rate of Premature Ovarian Failure at 2 Years","timeFrame":"2 years","effectByArm":[{"arm":"Standard Chemotherapy","deltaMin":15,"sd":null},{"arm":"Chemotherapy Plus Goserelin","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":34,"countries":["Australia","Belgium","Hungary","Italy","New Zealand","Switzerland"]},"refs":{"pmids":["25738668"],"seeAlso":["https://nctn-data-archive.nci.nih.gov/"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":111},"commonTop":["Hot flashes/flushes","Pain - Head/headache","Sweating (diaphoresis)","Mood alteration - depression","Mood alteration - anxiety"]}}